Current Reimbursement Situation of Advanced Therapy Medicinal Products (ATMP) in Germany- Which Strategy to Secure Adequate Funding?
Abstract
Authors
M Campion D Bot T Ecker
M Campion D Bot T Ecker
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now